(Q46641346)
Statements
1 reference
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment (English)
1 reference
M. D. Pegram
A. Lipton
D. F. Hayes
B. L. Weber
J. M. Baselga
D. Tripathy
D. Baly
S. A. Baughman
T. Twaddell
J. A. Glaspy
1 August 1998
1 reference
16
1 reference
8
1 reference
2659-2671
1 reference